The above data revealed that DPYSL2, LIMCH1, and PIK3R1 of the six key-gene signature were all downregulated in the samples with lymph node metastasis and in BoM, BrM, LnM, and LuM cells. This evidence concerns the gene DPYSL2 and metastatic malignant neoplasm in the lymph nodes.